Germany· DE-A57-93ab98ffc139558d
Mag-3 Kit
A medicinal product containing mertiatide, registered in Germany by Rotop Pharmaka Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Mertiatide
- Manufacturer
- Rotop Pharmaka Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mertiatide in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumNephroMAG 0.2 mgRotop Pharmaka
- SwitzerlandMAG-3 Kit, Markierungsbesteckmedeo AG
- SpainNEPHROMAG 200 microgramos EQUIPO DE REACTIVOS PARA PREPARACION RADIOFARMACEUTICARotop Pharmaka Gmbh
- FinlandNephromagRotop Pharmaka GmbH
- FranceNephroMAG 0,2 mg, trousse pour préparation radiopharmaceutiqueROTOP PHARMAKA (ALLEMAGNE)
- United KingdomIELMAG3 0.2mg kit for radiopharmaceutical preparationXiel Ltd
- IrelandIELMAG3 0.2 mg kit for radiopharmaceutical preparationROTOP Pharmaka GmbH
- NetherlandsNephroMAG 0,2 mg, kit voor radiofarmaceutisch preparaatROTOP Pharmaka GmBH
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Mertioscan
- Belgium · Nephromag
- Denmark · Nephromag
- Spain · Nephromag
- Finland · Nephromag
- France · Nephromag
- United Kingdom (Northern Ireland) · Ielmag3
- Ireland · Ielmag3
- Italy · Mag3
- Luxembourg · Nephromag
- Netherlands · Nephromag
- Norway · Nephromag
- Portugal · Mertioscan
- Sweden · Nephromag
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0f68afc6-20d8-48cb-a61e-8a7ee5d95414 GET /v1/drugs/0f68afc6-20d8-48cb-a61e-8a7ee5d95414?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Mertiatide",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about mertiatide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.